Cvergenx
An innovative leader in cancer molecular diagnostics, delivering personalized radiation therapy to enhance patient outcomes.
2 employees · est. 2009 · Tampa, United States
Viracta Therapeutics, Inc.
A precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients
31 employees · est. 2007 · United States
Viracta Therapeutics, Inc. is the older company (2009 vs 2007); Viracta Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Cvergenx | Viracta Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2009 | 2007 older |
| Headquarters | ||
| Headquarters | Tampa, United States | United States |
| Employees | ||
| Employees | 2 | 31 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | IPO |
| Total Funding | ||
| Total Funding | $225.55K | $143.40M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Not tracked yet | development of targeted cancer therapies |
| Target Customers | ||
| Target Customers | Not tracked yet | oncologists, cancer treatment centers, patients with cancer |
| Taxonomy | ||
| Taxonomy | Cancer Molecular Diagnostics, Personalized Radiation Therapy, Radiation Therapy, Cancer Care, Advanced Diagnostics, Precision Medicine, Oncology, Cancer Treatment, Patient Outcomes, Innovation, Precision Oncology, Therapeutics, Precision Medicine | Precision Oncology, Virus-Associated Cancers, Nanatinostat, Antiviral Therapy, EBV-Positive Lymphoma, Inducible Synthetic Lethality, Nasopharyngeal Carcinoma, Gastric Carcinoma, Epstein-Barr Virus, Lymphoproliferative Disorders, Immuno-Oncology, Phase 2 Clinical Trial, Oral Combination Therapy, Virus-Related Cancers, Valganciclovir |
| Website | ||
| Website | cvergenx.com | viracta.com |
About Cvergenx
CVERGENX is a pioneering company in the field of cancer molecular diagnostics, specializing in personalized radiation therapy tailored to optimize patient outcomes. With a strong focus on Biotechnology and Health Care industries, the company, founded in 2009, is headquartered in the United States....
About Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc., founded in 2007, is a cutting-edge company within the biopharma and biotechnology sectors, headquartered in the United States. As a precision oncology entity, it focuses on tackling virus-associated cancers, striving to enhance patient outcomes globally. The company's ap...
We will tell you when either one moves
BounceWatch watches Cvergenx and Viracta Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cvergenx and Viracta Therapeutics,... — by email.
Frequently Asked Questions
Compare Cvergenx with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cvergenx on 14 Sep 2024, and Viracta Therapeutics, Inc. on 26 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
